Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Characterization of Continuous and Pulsed Emission modes of a Hybrid Micro Focus X-ray Source for Medical Imaging Applications.

Ghani MU, Wong MD, Ren L, Wu D, Zheng B, Rong JX, Wu X, Liu H.

Nucl Instrum Methods Phys Res A. 2017 May 1;853:70-77. doi: 10.1016/j.nima.2017.02.030. Epub 2017 Feb 16.

2.

Defective enamel and bone development in sodium-dependent citrate transporter (NaCT) Slc13a5 deficient mice.

Irizarry AR, Yan G, Zeng Q, Lucchesi J, Hamang MJ, Ma YL, Rong JX.

PLoS One. 2017 Apr 13;12(4):e0175465. doi: 10.1371/journal.pone.0175465. eCollection 2017.

3.

Electrophysiological characterization of human and mouse sodium-dependent citrate transporters (NaCT/SLC13A5) reveal species differences with respect to substrate sensitivity and cation dependence.

Zwart R, Peeva PM, Rong JX, Sher E.

J Pharmacol Exp Ther. 2015 Nov;355(2):247-54. doi: 10.1124/jpet.115.226902. Epub 2015 Aug 31.

PMID:
26324167
4.

Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group.

Lobera M, Madauss KP, Pohlhaus DT, Wright QG, Trocha M, Schmidt DR, Baloglu E, Trump RP, Head MS, Hofmann GA, Murray-Thompson M, Schwartz B, Chakravorty S, Wu Z, Mander PK, Kruidenier L, Reid RA, Burkhart W, Turunen BJ, Rong JX, Wagner C, Moyer MB, Wells C, Hong X, Moore JT, Williams JD, Soler D, Ghosh S, Nolan MA.

Nat Chem Biol. 2013 May;9(5):319-25. doi: 10.1038/nchembio.1223. Epub 2013 Mar 24.

PMID:
23524983
5.

ACAT inhibition reduces the progression of preexisting, advanced atherosclerotic mouse lesions without plaque or systemic toxicity.

Rong JX, Blachford C, Feig JE, Bander I, Mayne J, Kusunoki J, Miller C, Davis M, Wilson M, Dehn S, Thorp E, Tabas I, Taubman MB, Rudel LL, Fisher EA.

Arterioscler Thromb Vasc Biol. 2013 Jan;33(1):4-12. doi: 10.1161/ATVBAHA.112.252056. Epub 2012 Nov 8.

6.

Rosiglitazone Induces Mitochondrial Biogenesis in Differentiated Murine 3T3-L1 and C3H/10T1/2 Adipocytes.

Rong JX, Klein JL, Qiu Y, Xie M, Johnson JH, Waters KM, Zhang V, Kashatus JA, Remlinger KS, Bing N, Crosby RM, Jackson TK, Witherspoon SM, Moore JT, Ryan TE, Neill SD, Strum JC.

PPAR Res. 2011;2011:179454. doi: 10.1155/2011/179454. Epub 2011 Oct 15.

7.

HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells.

Feig JE, Rong JX, Shamir R, Sanson M, Vengrenyuk Y, Liu J, Rayner K, Moore K, Garabedian M, Fisher EA.

Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):7166-71. doi: 10.1073/pnas.1016086108. Epub 2011 Apr 11. Erratum in: Proc Natl Acad Sci U S A. 2011 Aug 23;108(34):14371.

8.

Reversal of hyperlipidemia with a genetic switch favorably affects the content and inflammatory state of macrophages in atherosclerotic plaques.

Feig JE, Parathath S, Rong JX, Mick SL, Vengrenyuk Y, Grauer L, Young SG, Fisher EA.

Circulation. 2011 Mar 8;123(9):989-98. doi: 10.1161/CIRCULATIONAHA.110.984146. Epub 2011 Feb 21.

9.

Adipose mitochondrial biogenesis is suppressed in db/db and high-fat diet-fed mice and improved by rosiglitazone.

Rong JX, Qiu Y, Hansen MK, Zhu L, Zhang V, Xie M, Okamoto Y, Mattie MD, Higashiyama H, Asano S, Strum JC, Ryan TE.

Diabetes. 2007 Jul;56(7):1751-60. Epub 2007 Apr 24.

10.

Comparison of mitochondrial and macrophage content between subcutaneous and visceral fat in db/db mice.

Okamoto Y, Higashiyama H, Rong JX, McVey MJ, Kinoshita M, Asano S, Hansen MK.

Exp Mol Pathol. 2007 Aug;83(1):73-83. Epub 2007 Mar 12.

PMID:
17434481
11.

Acyl-coenzymeA (CoA):cholesterol acyltransferase inhibition in rat and human aortic smooth muscle cells is nontoxic and retards foam cell formation.

Rong JX, Kusunoki J, Oelkers P, Sturley SL, Fisher EA.

Arterioscler Thromb Vasc Biol. 2005 Jan;25(1):122-7. Epub 2004 Oct 21.

PMID:
15499046
12.

Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization.

Angeli V, LlodrĂ¡ J, Rong JX, Satoh K, Ishii S, Shimizu T, Fisher EA, Randolph GJ.

Immunity. 2004 Oct;21(4):561-74.

13.

High-density lipoproteins retard the progression of atherosclerosis and favorably remodel lesions without suppressing indices of inflammation or oxidation.

Choudhury RP, Rong JX, Trogan E, Elmalem VI, Dansky HM, Breslow JL, Witztum JL, Fallon JT, Fisher EA.

Arterioscler Thromb Vasc Biol. 2004 Oct;24(10):1904-9. Epub 2004 Aug 19.

PMID:
15319266
14.

Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading.

Rong JX, Shapiro M, Trogan E, Fisher EA.

Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13531-6. Epub 2003 Oct 27.

15.

The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages.

Feng B, Yao PM, Li Y, Devlin CM, Zhang D, Harding HP, Sweeney M, Rong JX, Kuriakose G, Fisher EA, Marks AR, Ron D, Tabas I.

Nat Cell Biol. 2003 Sep;5(9):781-92. Epub 2003 Aug 10.

PMID:
12907943
16.

Eliminating atherogenesis in mice by switching off hepatic lipoprotein secretion.

Lieu HD, Withycombe SK, Walker Q, Rong JX, Walzem RL, Wong JS, Hamilton RL, Fisher EA, Young SG.

Circulation. 2003 Mar 11;107(9):1315-21.

PMID:
12628954
17.

Serial, noninvasive, in vivo magnetic resonance microscopy detects the development of atherosclerosis in apolipoprotein E-deficient mice and its progression by arterial wall remodeling.

Choudhury RP, Fayad ZA, Aguinaldo JG, Itskovich VV, Rong JX, Fallon JT, Fisher EA.

J Magn Reson Imaging. 2003 Feb;17(2):184-9.

PMID:
12541225
18.

Lysophosphatidylcholine stimulates monocyte chemoattractant protein-1 gene expression in rat aortic smooth muscle cells.

Rong JX, Berman JW, Taubman MB, Fisher EA.

Arterioscler Thromb Vasc Biol. 2002 Oct 1;22(10):1617-23.

PMID:
12377739
19.

Atherosclerotic lesions in genetically modified mice quantified in vivo by non-invasive high-resolution magnetic resonance microscopy.

Choudhury RP, Aguinaldo JG, Rong JX, Kulak JL, Kulak AR, Reis ED, Fallon JT, Fuster V, Fisher EA, Fayad ZA.

Atherosclerosis. 2002 Jun;162(2):315-21.

PMID:
11996951
20.

Laser capture microdissection analysis of gene expression in macrophages from atherosclerotic lesions of apolipoprotein E-deficient mice.

Trogan E, Choudhury RP, Dansky HM, Rong JX, Breslow JL, Fisher EA.

Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):2234-9. Epub 2002 Feb 12.

21.

Elevating high-density lipoprotein cholesterol in apolipoprotein E-deficient mice remodels advanced atherosclerotic lesions by decreasing macrophage and increasing smooth muscle cell content.

Rong JX, Li J, Reis ED, Choudhury RP, Dansky HM, Elmalem VI, Fallon JT, Breslow JL, Fisher EA.

Circulation. 2001 Nov 13;104(20):2447-52.

PMID:
11705823
22.

Dramatic remodeling of advanced atherosclerotic plaques of the apolipoprotein E-deficient mouse in a novel transplantation model.

Reis ED, Li J, Fayad ZA, Rong JX, Hansoty D, Aguinaldo JG, Fallon JT, Fisher EA.

J Vasc Surg. 2001 Sep;34(3):541-7.

23.

High-density lipoprotein: gene-based approaches to the prevention of atherosclerosis.

Rong JX, Fisher EA.

Ann Med. 2000 Dec;32(9):642-51. Review.

PMID:
11209972
24.

Cholesterol oxidation products induce vascular foam cell lesion formation in hypercholesterolemic New Zealand white rabbits.

Rong JX, Shen L, Chang YH, Richters A, Hodis HN, Sevanian A.

Arterioscler Thromb Vasc Biol. 1999 Sep;19(9):2179-88.

PMID:
10479661
25.

Arterial injury by cholesterol oxidation products causes endothelial dysfunction and arterial wall cholesterol accumulation.

Rong JX, Rangaswamy S, Shen L, Dave R, Chang YH, Peterson H, Hodis HN, Chisolm GM, Sevanian A.

Arterioscler Thromb Vasc Biol. 1998 Dec;18(12):1885-94.

PMID:
9848880

Supplemental Content

Support Center